Oncologie

Onze wetenschappers en oncologen spannen zich in om de patiënten betere resultaten en een leven na de kanker te geven, door therapieën te ontwikkelen die de kwaliteit van de zorg verbeteren

Focusdomeinen in de oncologie

Wij focussen op oplossingen die de behandeling van kanker transformeren. We willen betere en blijvende resultaten bereiken voor bloedkankers en vaste tumoren. Onze cultuur van nieuwsgierigheid spoort ons aan om nieuwe oplossingen te ontdekken.


Bloedkankers

AbbVie SA/NV –BE-ABBV-240170 (1.0) – Decembre 2024

 

Referenties:

  1. Cancers hématologiques, Institut Curie, https://curie.fr/cancers-hematologiques, Last accessed December 2024.
  2. AML – Treatment outcomes, Leukemia & Lymphoma Society, https://www.lls.org/leukemia/acute-myeloid-leukemia/treatment/treatment-outcomes, Last accessed December 2024.
  3. Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®), National Cancer Institute. https://www.cancer.gov/types/leukemia/patient/child-all-treatment-pdq#link/_169 , Last accessed December 2024.
  4. Leukemia – Chronic Lymphocytic Leukemia, American Cancer Society. https://www.cancer.org/cancer/chronic-lymphocytic-leukemia/about/what-is-cll.html Last accessed December 2024.
  5. About Lymphoma- Diffuse Large B-Cell Lymphoma, Lymphoma Research Foundation. https://www.lymphoma.org/aboutlymphoma/nhl/dlbcl/. Last accessed December 2024.
  6. Lymphome à cellules du manteau, Leukemia & Lymphoma Society, https://www.lls.org/sites/default/files/National/USA/Pdf/Publications/FS4F_FR_MCL_Facts_2018.pdf, Last accessed December 2024.
  7. Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin Oncol. 2016;43(6):676-681. doi:10.1053/j.seminoncol.2016.11.004
  8. Syndromes myélodysplasiques, Société canadienne du cancer, https://cancer.ca/fr/cancer-information/cancer-types/leukemia/what-is-leukemia/myelodysplastic-syndromes#:~:text=Les%20syndromes%20my%C3%A9lodysplasiques%20(SMD)%20forment,qui%20ne%20fonctionnent%20pas%20correctement, Last accessed December 2024.
  9. Myelofibrosis, Leukemia and Lymphoma Society.  https://www.lls.org/myeloproliferative-neoplasms/myelofibrosis, Last accessed December 2024.
  10. Momenimovahed Z, et al. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287-299. Published 2019 Apr 30. doi:10.2147/IJWH.S197604
  11. Institut Roi Albert II, Cancer de l’ovaire, https://www.institutroialbertdeux.be/fr/cancer/cancer-de-lovaire#:~:text=Le%20cancer%20de%20l'ovaire,cas%20par%20an%20en%20Belgique., Last accessed December 2024.
  12. Institut National du cancer, Cancers de l’ovaire : les médicaments anticancéreux, https://www.e-cancer.fr/Patients-et-proches/Les-cancers/Cancer-de-l-ovaire/La-chimiotherapie-et-les-therapies-ciblees, Last accessed December 2024.
  13. Kim, A., Ueda, Y., Naka, T. et al. Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res 31, 14 (2012). https://doi.org/10.1186/1756-9966-31-14
  14. Dyba T, Randi G, Bray F, et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308-347. doi:10.1016/j.ejca.2021.07.039
  15. Chen C, Stock C, Hoffmeister M, Brenner H. Self-Reported Lower Gastrointestinal Endoscopy Use and Changes in Colorectal Cancer Mortality Rates in European Countries. Clin Transl Gastroenterol. 2020;11(10):e00243. doi:10.14309/ctg.0000000000000243
  16. Lackman MJ, Wilkinson AN. Le cancer du côlon en soins primaires. Can Fam Physician. 2024;70(1):e14-e19. doi:10.46747/cfp.7001e14
  17. Li F, Lin Y, Li R, et al. Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches. Front Pharmacol. 2023;14:1165666. Published 2023 Oct 20.